Aclarion Management

Management criteria checks 4/4

Aclarion's CEO is Brent Ness, appointed in Sep 2021, has a tenure of 3.25 years. total yearly compensation is $300.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.012% of the company’s shares, worth $159.99. The average tenure of the management team and the board of directors is 3.2 years and 3.3 years respectively.

Key information

Brent Ness

Chief executive officer

US$300.0k

Total compensation

CEO salary percentage100.0%
CEO tenure3.3yrs
CEO ownership0.01%
Management average tenure3.2yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brent Ness's remuneration changed compared to Aclarion's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$6m

Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$300kUS$300k

-US$5m

Sep 30 2023n/an/a

-US$5m

Jun 30 2023n/an/a

-US$5m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$509kUS$300k

-US$7m

Sep 30 2022n/an/a

-US$8m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$6m

Dec 31 2021US$526kUS$100k

-US$6m

Compensation vs Market: Brent's total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Brent's compensation has been consistent with company performance over the past year.


CEO

Brent Ness (57 yo)

3.3yrs

Tenure

US$300,000

Compensation

Mr. Brent Ness has been President of Aclarion, Inc. (fka Nocimed, Inc.) since October 1, 2021 and its Chief Executive Officer & Director since September 15, 2021. From December 2019 to April 2021, Mr. Ness...


Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Thramann
Executive Chairman4.3yrsUS$300.00k0%
$ 0
Brent Ness
CEO, President & Director3.3yrsUS$300.00k0.012%
$ 160.0
John Lorbiecki
Chief Financial Officer3.2yrsUS$225.00k0.013%
$ 174.8
Ryan Bond
Chief Strategy Officer3.3yrsUS$200.00k0.012%
$ 156.1

3.2yrs

Average Tenure

58yo

Average Age

Experienced Management: ACON's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jeffrey Thramann
Executive Chairman4.3yrsUS$300.00k0%
$ 0
Brent Ness
CEO, President & Director3.3yrsUS$300.00k0.012%
$ 160.0
William Wesemann
Lead Independent Director8.9yrsUS$40.00k0.032%
$ 411.7
Jeffrey Lotz
Member of Scientific Advisory Boardno dataUS$12.86kno data
Stephen Deitsch
Independent Director2.7yrsUS$45.00k0%
$ 0
Scott Breidbart
Independent Director2.7yrsUS$40.00k0%
$ 0
Robert Eastlack
Member of Medical Advisory Boardno dataUS$14.77kno data
David Neal
Director8.3yrsUS$25.00k0.11%
$ 1.5k
Amanda Williams
Independent Director2.7yrsUS$35.00k0%
$ 0
Lawrence Tannenbaum
Member of Medical Advisory Boardno dataUS$10.40kno data

3.3yrs

Average Tenure

58yo

Average Age

Experienced Board: ACON's board of directors are considered experienced (3.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 15:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aclarion, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lucas WardAscendiant Capital Markets LLC
Anthony VendettiMaxim Group